prednisolone has been researched along with Hyperphosphatemia in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Hyperphosphatemia: A condition of abnormally high level of PHOSPHATES in the blood, usually significantly above the normal range of 0.84-1.58 mmol per liter of serum.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhavani, N | 1 |
| Praveen, VP | 1 |
| Jayakumar, RV | 1 |
| Nair, V | 1 |
| Muraleedharan, M | 1 |
| Kuma, H | 1 |
| Unnikrishnan, AG | 1 |
| Menon, VU | 1 |
1 other study available for prednisolone and Hyperphosphatemia
| Article | Year |
|---|---|
Hypercalcemia with renal failure.
Topics: Acute Kidney Injury; Glucocorticoids; Humans; Hypercalcemia; Hyperphosphatemia; Male; Middle Aged; N | 2012 |